Management of surgical hemostasis: systemic agents

Area of Science:

• Anesthesiology and Perioperative Medicine
• Hematology
• Pharmacology

Background:

• Perioperative bleeding remains a significant clinical challenge, even with improved surgical techniques.
• Current management relies heavily on allogeneic blood product transfusions, which are associated with adverse events.
• Reducing reliance on transfusions is crucial for improving patient safety during surgery.

Purpose of the Study:

• To review systemic pharmacologic prohemostatic agents for managing perioperative bleeding.
• To discuss the role of these agents in reducing the need for allogeneic transfusions.
• To highlight therapeutic approaches to mitigate perioperative hemorrhage.

Main Methods:

• Literature review of systemic pharmacologic prohemostatic agents.
• Discussion of agents including aprotinin, lysine analogues, protamine, desmopressin, and recombinant factor VIIa.
• Analysis of their application in preventing or decreasing perioperative bleeding.

Main Results:

• Systemic prohemostatic agents offer alternative strategies to blood transfusion.
• These agents can potentially reduce the incidence and severity of perioperative bleeding.
• Pharmacologic interventions are important for minimizing transfusion-related complications.

Conclusions:

• Systemic prohemostatic agents represent a valuable therapeutic option in managing perioperative bleeding.
• Optimizing the use of these agents can decrease the need for allogeneic transfusions.
• Further research and clinical application of these agents can enhance patient safety and outcomes.